Guanhao BiotechLtd Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Yongming Zhang
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 1.6yrs |
| Board average tenure | 4.8yrs |
Recent management updates
Recent updates
Solid Earnings May Not Tell The Whole Story For Guanhao BiotechLtd (SZSE:300238)
Nov 04
Subdued Growth No Barrier To Guanhao Biotech Co.,Ltd. (SZSE:300238) With Shares Advancing 38%
Oct 24Optimistic Investors Push Guanhao Biotech Co.,Ltd. (SZSE:300238) Shares Up 28% But Growth Is Lacking
Sep 02Guanhao Biotech Co.,Ltd. (SZSE:300238) May Have Run Too Fast Too Soon With Recent 28% Price Plummet
Jun 07Guanhao Biotech Co.,Ltd.'s (SZSE:300238) 26% Share Price Plunge Could Signal Some Risk
Apr 23Guanhao Biotech Co.,Ltd.'s (SZSE:300238) 32% Share Price Surge Not Quite Adding Up
Mar 09CEO
Yongming Zhang (52 yo)
less than a year
Tenure
Mr. Yongming Zhang serves as Non-Independent Director and Non-Independent Chairman at Guanhao Biotech Co. Ltd. since April 27, 2018 and also serves as its General Manager since January 12, 2024.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Non-Independent Chairman & GM | less than a year | no data | no data | |
| Deputy GM & Secretary | 1.6yrs | CN¥584.90k | no data | |
| Deputy General Manager | 1.6yrs | CN¥918.60k | 0.0057% CN¥ 181.3k | |
| Deputy General Manager | 4.9yrs | CN¥1.62m | 0.0052% CN¥ 166.9k | |
| Deputy General Manager | 3.8yrs | CN¥888.60k | no data | |
| Deputy General Manager | 1.6yrs | CN¥701.30k | no data | |
| Deputy General Manager | 1.6yrs | CN¥701.30k | no data | |
| Chief Financial Officer | less than a year | no data | no data | |
| Chief Technology Officer | no data | CN¥541.70k | no data |
1.6yrs
Average Tenure
46yo
Average Age
Experienced Management: 300238's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Non-Independent Chairman & GM | 6.8yrs | no data | no data | |
| Vice Chairman | 4.5yrs | CN¥1.15m | no data | |
| Independent Director | 1.6yrs | CN¥53.00k | no data | |
| Non-Employee Supervisor | 4.8yrs | no data | no data | |
| Chairman of the Supervisory Board | 4.8yrs | no data | no data | |
| Independent Director | 4.8yrs | CN¥100.00k | no data | |
| Non-Independent Director | 4.8yrs | no data | no data | |
| Supervisor | 4.8yrs | no data | no data |
4.8yrs
Average Tenure
53yo
Average Age
Experienced Board: 300238's board of directors are considered experienced (4.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/09 10:37 |
| End of Day Share Price | 2025/01/09 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Guanhao Biotech Co.,Ltd. is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Xin Zhang | AJ Securities Co., Ltd |
| Hui Chen | Bohai Securities Co., Ltd. |
| YANG QIAO | Changjiang Securities Co. LTD. |